You have 9 free searches left this month | for more free features.

CAR-T Therapy

Showing 26 - 50 of >10,000


Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023

Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

  • Malignant Neoplasm
  • +4 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Acute Lymphoblastic Leukemia
  • CD19 Directed CAR T Cell
  • Aurora, Colorado
    University of Colorado Hospital
Sep 12, 2022

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Study of CAR-T Therapy in Older Patients

  • Lymphoma
  • +5 more
  • Activities of Daily Living/ADLs
  • +10 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Lymphoma, B-Cell Trial in Langfang (CD19 and CD22 targeted CAR-T cells)

Not yet recruiting
  • Lymphoma, B-Cell
  • CD19 and CD22 targeted CAR-T cells
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Dec 6, 2022

Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

  • CAR-T Therapy Complications
    • Bologna, Italy
      IRCC, University Hospital of Bologna
    Mar 18, 2022

    Non-Hodgkin Lymphoma Trial in Dallas (Focal radiation therapy (RT))

    • Non-Hodgkin Lymphoma
    • Focal radiation therapy (RT)
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 8, 2022

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +2 more
    • Miami, Florida
      University of Miami
    Aug 3, 2022

    Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

    • Hematologic Malignancy
    • Blood draw
    • Durham, North Carolina
      Duke University
    Jun 22, 2022

    DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Pembroke Pines, Florida
    • +3 more
    Jan 23, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    CB-Long-Term Safety Study (CB-LTSS)

    Enrolling by invitation
    • Lymphoma, Non-Hodgkin
    • +7 more
    • Allogeneic CAR-T therapy
    • Irvine, California
    • +3 more
    Nov 18, 2022

    CAR-T Treatment for Hematological Malignancies

    • Hematological Malignancies
    • Chimeric Antigen Receptor T-cell Therapy
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Sep 11, 2023

      Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

      Active, not recruiting
      • Hematologic Malignancy
      • CAR-T Cell Therapy
      • Educational Video Tool
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jan 24, 2023

      Lymphoma Patients Undergoing CAR-T Cell Therapy: FIL_SAR-CAR

      Not yet recruiting
      • Non-hodgkin Lymphoma,B Cell
      • Chimeric Antigen Receptor T-cells (CAR-T) therapy
      • Alessandria, Italy
      • +20 more
      Nov 27, 2023

      Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

      Not yet recruiting
      • Lymphoma
      • +2 more
      • Web Application
      • San Francisco, California
        University of California, San Francisco
      Oct 4, 2022

      CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

      • CAR-T Cell Therapy
      • GC012F injection
      • Shanghai, Shanghai, China
        Department of Rheumatology, Ren Ji Hospital South Campus, School
      May 5, 2023

      Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

      • Gastric Cancer
      • +2 more
      • KD-496
      • Beijing, China
        Chinese PLA General Hospital
      Oct 13, 2022

      Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

      Not yet recruiting
      • Hematologic Malignancy
      • +5 more
      • autologous hematopoietic stem cells added to planned CAR T
      • Los Angeles, California
        Cedars-Sinai Medical Center
      May 31, 2023

      Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

      Not yet recruiting
      • Non Hodgkin's Lymphoma
      • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
      • +2 more
      • Beijing, China
      • +2 more
      Aug 23, 2023